Glucocorticoid signaling and osteoarthritis.
Glucocorticoid
Homeostasis
Inflammation
Osteoarthritis
Receptor
Signaling
Journal
Molecular and cellular endocrinology
ISSN: 1872-8057
Titre abrégé: Mol Cell Endocrinol
Pays: Ireland
ID NLM: 7500844
Informations de publication
Date de publication:
15 01 2019
15 01 2019
Historique:
received:
11
05
2018
revised:
03
10
2018
accepted:
11
11
2018
pubmed:
18
11
2018
medline:
18
5
2019
entrez:
17
11
2018
Statut:
ppublish
Résumé
Glucocorticoids are steroid hormones synthesized and released by the adrenal cortex. Their main function is to maintain cell homeostasis through a variety of signaling pathways, responding to changes in an organism's environment or developmental status. Mimicking the actions of natural glucocorticoids, synthetic glucocorticoids have been recruited to treat many diseases that implicate glucocorticoid receptor signaling such as osteoarthritis. In osteoarthritis, synthetic glucocorticoids aim to alleviate inflammation and pain. The variation of patients' response and the possibility of complications associated with their long-term use have led to a need for a better understanding of glucocorticoid receptor signaling in osteoarthritis. In this review, we performed a literature search in the molecular pathways that link the osteoarthritic joint to the glucocorticoid receptor signaling. We hope that this information will advance research in the field and propose new molecular targets for the development of more optimized therapies for osteoarthritis.
Identifiants
pubmed: 30445185
pii: S0303-7207(18)30319-8
doi: 10.1016/j.mce.2018.11.001
pii:
doi:
Substances chimiques
Glucocorticoids
0
Receptors, Glucocorticoid
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
153-166Informations de copyright
Copyright © 2018 Elsevier B.V. All rights reserved.